-The Hindu Business Line The negotiations must be conducted in a transparent manner especially on issues regarding intellectual property Every time countries negotiate a trade deal, public health workers are forced to keep their ear to the ground, to ensure there is no trade-off on health. And that seems to be the case this time too, in the build-up to the proposed Free Trade Agreement (FTA) between India and the United Kingdom. Leaked...
More »SEARCH RESULT
Total Matching Records found : 41
On Covid patents waiver, health cannot be held hostage to profit -Rajshree Chandra
-The Indian Express Innovation in vaccine production can have an impact only if it is accessible to all. Patents and access to life-saving drugs has always been an emotive and contentious issue. The right to healthy life is a moral minimum, and to find a rational basis to deny it is deeply offensive to the idea of life itself. At the same time, pharma corporations and institutions claim patents are a just...
More »Price of new lifesaving TB drug, Pretomanid, too high, says MSF -M Somasekhar
-The Hindu Business Line The drug was developed by the TB Alliance, funded by various governments and philanthropic sources Hyderabad: The slew of newer TB drugs that have hit the market recently promise to tackle the disease better, but the high price can prove a dampener to realise the goal of taming the deadly disease on a war footing, feel experts, advocacy groups and medical organisations who are meeting this week in...
More »India shocks with vaccine patent -Latha Jishnu
-Down to Earth Why did we grant Pfizer's claim on a pneumonia vaccine which has been rejected elsewhere? In august, the medical and public health fraternity was stunned when India’s Patent Office granted US pharma giant Pfizer’s claim on its vaccine against pneumonia, the pneumococcal conjugate vaccine (PCV), marketed as Prevnar13. For a country that has stricter patentability criteria than most others, India’s decision was baffling because Pfizer’s patent has been rejected...
More »Generic medicines in a digital age -Dinesh S Thakur & Prashant Reddy T
-The Hindu We need a legal mechanism to ensure that all generics are of the same standard as the innovator product The Prime Minister’s recent announcement on making it mandatory for doctors to prescribe only the generic name, and not brand name of a drug, has led to a flutter. If enacted, the move will make it illegal for Indian doctors to write out a prescription for the trademark of the drug,...
More »
